KEGG   DRUG: Vorinostat
Entry
D06320                      Drug                                   
Name
Vorinostat (JAN/USAN);
Zolinza (TN)
Product
ZOLINZA (Merck Sharp & Dohme LLC)
Formula
C14H20N2O3
Exact mass
264.1474
Mol weight
264.3202
Structure
Class
Antineoplastic
 DG03133  Histone deacetylase inhibitor
Metabolizing enzyme substrate
 DG02924  UGT substrate
Remark
Therapeutic category: 4291
ATC code: L01XH01
Product: D06320<JP/US>
Efficacy
Antineoplastic, Histone deacetylase inhibitor
  Disease
Cutaneous T-cell lymphoma [DS:H01463]
Target
HDAC [HSA:3065 3066 8841 9759 10014 10013 51564 55869 9734 83933 79885] [KO:K06067 K11404 K11406 K11407 K11408 K11405 K11409 K18671 K11418]
  Pathway
hsa04110  Cell cycle
hsa04330  Notch signaling pathway
hsa05200  Pathways in cancer
Metabolism
Enzyme: UGT [KO:K00699]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XH Histone deacetylase (HDAC) inhibitors
     L01XH01 Vorinostat
      D06320  Vorinostat (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Molecular Target Inhibitors
   Vorinostat
    D06320  Vorinostat (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D06320  Vorinostat (JAN/USAN)
Drug groups [BR:br08330]
 Antineoplastic
  DG03133  Histone deacetylase inhibitor
   D06320  Vorinostat
 Metabolizing enzyme substrate
  DG02924  UGT substrate
   D06320  Vorinostat
Target-based classification of drugs [BR:br08310]
 Enzymes
  Hydrolases (EC3)
   Histone deacetylase
    HDAC
     D06320  Vorinostat (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D06320
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D06320
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D06320
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D06320
Other DBs
CAS: 149647-78-9
PubChem: 47207977
ChEBI: 45716
PDB-CCD: SHH[PDBj]
LigandBox: D06320
KCF data

ATOM        19
            1   C8x C    18.0545  -17.1308
            2   C8x C    18.0545  -18.5347
            3   C8x C    19.2703  -19.2367
            4   C8x C    20.4863  -18.5347
            5   C8y C    20.4863  -17.1308
            6   C8x C    19.2703  -16.4288
            7   O5a O    22.9179  -18.5347
            8   C5a C    22.9179  -17.1308
            9   N1b N    21.7021  -16.4288
            10  C1b C    24.1189  -16.4374
            11  C1b C    25.3106  -17.1252
            12  C1b C    26.5446  -16.4060
            13  C1b C    27.7538  -17.1042
            14  C1b C    28.9630  -16.4060
            15  C1b C    30.1721  -17.1042
            16  C5a C    31.3814  -16.4060
            17  N1b N    32.5905  -17.1042
            18  O1b O    33.7997  -16.4060
            19  O5a O    31.3814  -15.0101
BOND        19
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 2
            8     8   9 1
            9     5   9 1
            10    8  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   16  19 2

» Japanese version   » Back

  All links  
Ontology (9)   
   KEGG BRITE (9)   
Disease (1)   
   KEGG DISEASE (1)   
Drug (3)   
   KEGG DGROUP (2)   
   LigandBox (1)   
Chemical substance (4)   
   PubChem (1)   
   ChEBI (1)   
   HMDB (1)   
   PDB-CCD (1)   
Gene (20)   
   KEGG ORTHOLOGY (9)   
   KEGG GENES (11)   
All databases (37)   

Download RDF
DBGET integrated database retrieval system